| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 12/27/2001 | CA2413986A1 Gp354 nucleic acids and polypeptides |
| 12/27/2001 | CA2413866A1 Compositions and methods of monoclonal and polyclonal antibodies specific for t cell subpopulations |
| 12/27/2001 | CA2413502A1 Tumour-cell specific gene expression and its use in cancer therapy |
| 12/27/2001 | CA2413468A1 Methods and means for regulation of gene expression |
| 12/27/2001 | CA2413454A1 A g-protein coupled receptor |
| 12/27/2001 | CA2413435A1 A recombinant cell line expressing gpcrx11 as a functional receptor validated by angiopeptin and useful for screening of agonists and antagonists |
| 12/27/2001 | CA2413421A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413418A1 Piperidine amides as modulators of chemokine receptor activity |
| 12/27/2001 | CA2413328A1 Pharmaceuticals for the imaging of angiogenic disorders for use in combination therapy |
| 12/27/2001 | CA2413274A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
| 12/27/2001 | CA2412901A1 Bispecific fusion protein and method of use for enhancing effector cell killing of target cells |
| 12/27/2001 | CA2412849A1 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 12/27/2001 | CA2412484A1 G-protein coupled receptors |
| 12/27/2001 | CA2412215A1 Angiogenesis-modulating compositions and uses |
| 12/27/2001 | CA2412054A1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives, taxanes and/or antimetabolites |
| 12/27/2001 | CA2411971A1 Proteases |
| 12/27/2001 | CA2411865A1 Azaindole derivatives, process for their preparation, and their use as antitumor agents |
| 12/27/2001 | CA2411826A1 Liposomal encapsulation of chelated actinium-225 and uses thereof |
| 12/27/2001 | CA2411236A1 Combinations and compositions which interfere with vegf/vegf and angiopoietin/tie receptor function and their use (ii) |
| 12/27/2001 | CA2411102A1 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 12/27/2001 | CA2410864A1 Compositions comprising net-4 modulations and their use for treating neoplastic disease |
| 12/27/2001 | CA2410632A1 Nitrosated and nitrosylated taxanes, compositions and methods of use |
| 12/27/2001 | CA2410371A1 Methods for enhancing antibody-induced cell lysis and treating cancer |
| 12/27/2001 | CA2410208A1 Systems and methods for treating a mucosal surface |
| 12/27/2001 | CA2409778A1 Secreted proteins |
| 12/27/2001 | CA2409776A1 G-protein coupled receptors |
| 12/26/2001 | CN1328571A Human monoclonal antibodies to CTLA-4 |
| 12/26/2001 | CN1328570A Antagonistic analogs in GH-RH inhibiting IGF-I and -II |
| 12/26/2001 | CN1328566A Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation |
| 12/26/2001 | CN1328550A Oxazole compounds as prostaglandin E2 agonists or antagonists |
| 12/26/2001 | CN1328545A Hydrazine derivatives |
| 12/26/2001 | CN1328538A 2,4-pentadienoic acid derivatives having selective activity for retinoid X(RXR) receptors |
| 12/26/2001 | CN1328469A Use of parvovirus capsid particles in inhibition of cell proliferation and migration |
| 12/26/2001 | CN1328144A Polypeptide-methylated-DNA-protein-casteine methyltransferase 10 and polynucleotide for coding it |
| 12/26/2001 | CN1328059A Polypeptide-human cell cyclin G29.13 and polynucleotide for coding it |
| 12/26/2001 | CN1328057A Polypeptide-human FK506 bindin 12.32 and polynucleotide for coding it |
| 12/26/2001 | CN1328055A Polypeptide-insulin-like growth factor bindin 16.17 and polynucleotide for coding it |
| 12/26/2001 | CN1328043A Polypeptide-human periplastic dynein intermediate chain (IC) 9.35 and polynucleotide for coding it |
| 12/26/2001 | CN1328009A Polypeptide-Ras GTP enzyme activated protein 12 and polynucleotide for coding it |
| 12/26/2001 | CN1327987A Polypeptide-nclein matrix antigen 110.34 and polynucleotide for coding it |
| 12/26/2001 | CN1327855A Gene expressed switchable molecular medicine |
| 12/26/2001 | CN1327853A Stable alpha-interferon preparation |
| 12/26/2001 | CN1327850A American ginseng extract (CNT-2000) without residual agricultural chemical and its usage |
| 12/26/2001 | CN1327823A Anticancer grape beverage |
| 12/26/2001 | CN1327808A Hualin Plaster for treating thyrome and its preparing process and prescription |
| 12/26/2001 | CN1327807A Chinese medicine for treating neoplasm |
| 12/26/2001 | CN1327793A Pyrrolo-triazine and pyrimidine compounds |
| 12/26/2001 | CA2350043A1 Novel melanocortin -4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate |
| 12/25/2001 | US6333422 Thermosensitive cyclotriphosphazene-platinum complex conjugate, its preparation method and anticancer agent containing the same |
| 12/25/2001 | US6333419 Chromatographic separation method of paclitaxel and cephalomannin |
| 12/25/2001 | US6333410 Process for the preparation and purification of thiol-containing maytansinoids |
| 12/25/2001 | US6333348 Use of docetaxel for treating cancers |
| 12/25/2001 | US6333346 Aminofuranoneureas or thioureas 4-amino-2(5h)-thiophenones as antitumor agents |
| 12/25/2001 | US6333343 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents |
| 12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
| 12/25/2001 | US6333335 To inhibit prenyl-protein transferase and the prenylation of the oncogene protein ras |
| 12/25/2001 | US6333331 Useful in inactivating the human dna repair protein o.sup.6 -alkylguanine-dna alkyltransferase; anticancer agents |
| 12/25/2001 | US6333319 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 12/25/2001 | US6333311 Has inflammatory and immune response functions such as regulation of monocyte colony stimulating factor synthesis, regulation of interleukin synthesis, activation of natural killer cell activity, inhibition of metastasis |
| 12/25/2001 | US6333168 Cloning, expression and uses of dorsalin-1 |
| 12/25/2001 | CA2066728C Anti-tumor preparation comprising interleukin-2 and histamine, analogs thereof or h2-receptor agonists |
| 12/20/2001 | WO2001096603A2 Methods to identify polynucleotide and polypeptide sequences which may be associated with physiological and medical conditions |
| 12/20/2001 | WO2001096586A1 Antisense modulation of c/ebp alpha expression |
| 12/20/2001 | WO2001096567A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/20/2001 | WO2001096566A1 Gasc1 gene |
| 12/20/2001 | WO2001096565A2 Binding agents: chimeric ligand/receptor proteins |
| 12/20/2001 | WO2001096564A2 Hla-g (hla-g7) isoform and its applications |
| 12/20/2001 | WO2001096558A1 Polyfunctional base sequence and artificial gene containing the same |
| 12/20/2001 | WO2001096553A1 Novel g protein-coupled receptor protein and dna thereof |
| 12/20/2001 | WO2001096547A2 Human kinases |
| 12/20/2001 | WO2001096546A2 Protein phosphatases |
| 12/20/2001 | WO2001096542A2 A human aminotransferase (23680) and uses thereof |
| 12/20/2001 | WO2001096534A1 A novel polypeptide, a atp-dependant human rna helicase 11 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096525A2 A novel polypeptide, a pogo conversion unit 18 and the polynucleotide encoding the polypeptide |
| 12/20/2001 | WO2001096523A2 Polynucleotides related to colon cancer |
| 12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
| 12/20/2001 | WO2001096395A2 Biosynthetic oncolytic molecules and uses therefor |
| 12/20/2001 | WO2001096390A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096388A2 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | WO2001096376A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins |
| 12/20/2001 | WO2001096372A2 Zinc transporters proteins and their use in medicinal preparations |
| 12/20/2001 | WO2001096367A1 Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 12/20/2001 | WO2001096360A1 Antisense modulation of c/ebp beta expression |
| 12/20/2001 | WO2001096354A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | WO2001096352A1 Rhodomycinone-derivatives |
| 12/20/2001 | WO2001096347A1 HMG-CoA REDUCTASE INHIBITORS AND METHOD |
| 12/20/2001 | WO2001096346A1 Tricyclic compounds as mrp1-inhibitors |
| 12/20/2001 | WO2001096343A1 Substituted metal-phthalocyanines, their preparation and the use thereof |
| 12/20/2001 | WO2001096339A1 Novel telomerase inhibitors |
| 12/20/2001 | WO2001096336A2 6,5-fused bicyclic heterocycles |
| 12/20/2001 | WO2001096334A2 Heteroarylalkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
| 12/20/2001 | WO2001096323A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096311A2 Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases |
| 12/20/2001 | WO2001096310A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists |
| 12/20/2001 | WO2001096307A2 Cycloalkyl alkanoic acids as integrin receptor antagonists |
| 12/20/2001 | WO2001096305A1 Serine protease inhibitors |
| 12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
| 12/20/2001 | WO2001096300A1 Growth hormone secretagogues |
| 12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |